Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Eisai 5,877.00 -25.00 -0.42% -25.32%
Acadia Pharmaceuticals 21.53 -0.40 -1.82% -56.54%
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
ALKERMES 24.56 -0.47 -1.88% 15.85%
Amgen 224.00 1.54 0.69% -9.59%
Aptinyx Inc 3.14 -0.16 -4.85% -14.21%
Arena Pharmaceuticals 89.79 0.16 0.18% 15.86%
Biogen 218.94 -0.40 -0.18% -18.27%
Enanta Pharmaceuticals 56.06 -1.27 -2.22% 21.66%
Esperion Therapeutics 3.65 -0.27 -6.89% -88.64%
Gilead Sciences 67.27 -0.07 -0.10% 4.00%
Intercept Pharmaceuticals 14.44 -0.75 -4.84% -60.77%
Incyte Corp 72.26 -1.26 -1.71% -20.83%
Intra Cellular Therapies 45.46 -2.27 -4.76% 41.14%
Marinus Pharmaceuticals 9.43 -0.25 -2.58% -24.74%
Neurocrine Biosciences 72.45 -3.06 -4.05% -35.27%
Minerva Neurosciences 0.74 0.01 1.18% -76.74%
PTC Therapeutics 38.52 -1.02 -2.56% -31.67%
Regeneron Pharmaceuticals 608.72 2.52 0.42% 20.24%
Sarepta Therapeutics 66.88 -3.36 -4.78% -25.80%
Supernus Pharmaceuticals 29.02 -0.34 -1.16% -3.78%
UCB 87.22 -0.50 -0.57% 0.37%
Vertex Pharmaceuticals 228.22 1.63 0.72% -0.79%
Zogenix 25.93 0 0% 35.40%

Indexes Price Day Year
NASDAQ 13353 -189.34 -1.40% 0.12%

Marinus Pharmaceuticals
Marinus Pharmaceuticals Inc is a United States-based biopharmaceutical company. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric disorders such as epilepsy, post-traumatic stress, and fragile-x syndrome. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings.